NextCure Depreciation & Amortization Growth & History (NXTC)
NextCure's depreciation and amortization was $2.2M for fiscal 2025.
View full NextCure company overviewNextCure annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.2M | −$700,000 | −24.14% |
| 2024 | 2024-12-31 | $2.9M | −$800,000 | −21.62% |
| 2023 | 2023-12-31 | $3.7M | −$400,000 | −9.76% |
| 2022 | 2022-12-31 | $4.1M | −$200,000 | −4.65% |
| 2021 | 2021-12-31 | $4.3M | $900,000 | +26.47% |
| 2020 | 2020-12-31 | $3.4M | $712,000 | +26.49% |
| 2019 | 2019-12-31 | $2.7M | $1.0M | +60.29% |
| 2018 | 2018-12-31 | $1.7M | — | — |
NextCure quarterly depreciation and amortization
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $272,000 | −$361,000 | −57.03% |
| Q1 2026 | 2026-03-31 | $283,000 | — | — |
| Q4 2025 | 2025-12-31 | $365,000 | — | — |
| Q3 2025 | 2025-09-30 | $533,000 | — | — |
| Q2 2025 | 2025-06-30 | $633,000 | — | — |
| Q3 2021 | 2021-09-30 | $2.1M | $1.2M | +136.84% |
| Q2 2021 | 2021-06-30 | $1.9M | $1.1M | +140.41% |
| Q1 2021 | 2021-03-31 | $1.1M | $354,000 | +47.14% |
| Q3 2020 | 2020-09-30 | $885,000 | $97,000 | +12.31% |
| Q2 2020 | 2020-06-30 | $787,000 | $205,000 | +35.22% |
| Q1 2020 | 2020-03-31 | $751,000 | $188,000 | +33.39% |
| Q3 2019 | 2019-09-30 | $788,000 | $392,000 | +98.99% |
| Q2 2019 | 2019-06-30 | $582,000 | $195,000 | +50.39% |
| Q1 2019 | 2019-03-31 | $563,000 | $187,000 | +49.73% |
| Q3 2018 | 2018-09-30 | $396,000 | — | — |
| Q2 2018 | 2018-06-30 | $387,000 | — | — |
| Q1 2018 | 2018-03-31 | $376,000 | — | — |
NextCure depreciation and amortization trends
Over the last five fiscal years, NextCure's depreciation and amortization decreased from $3.4M to $2.2M, a change of −$1.2M. The latest reported quarter, Q2 2026, shows $272,000.
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NextCure source filings ↗